MAP PHARMACEUTICALS, INC. Interest Expense
MAP PHARMACEUTICALS, INC. reported Interest Expense of $7.31 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. interest expense for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- MAP PHARMACEUTICALS, INC. interest expense for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- MAP PHARMACEUTICALS, INC. interest expense for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- MAP PHARMACEUTICALS, INC. interest expense for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- MAP PHARMACEUTICALS, INC. interest expense for fiscal 2011 was $316.00K, a 74.56% decline from fiscal 2010.
- MAP PHARMACEUTICALS, INC. interest expense for fiscal 2010 was $1.24M, a 41.36% decline from fiscal 2009.
- MAP PHARMACEUTICALS, INC. interest expense for fiscal 2009 was $2.12M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 96 month | Interest Expense 99 month | Interest Expense 102 month | Interest Expense 105 month | Interest Expense 108 month | Interest Expense 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 111 month − 10-Q 108 month · filed 2012-11-06 | $0.00 derived: sum of 2 quarters · filed 2012-11-06 | $0.00 derived: sum of 3 quarters · filed 2012-11-06 | $0.00 derived: sum of 4 quarters · filed 2012-11-06 | $7.31M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $0.00 derived: 10-Q 108 month − 10-Q 105 month · filed 2012-07-27 | $0.00 derived: sum of 2 quarters · filed 2012-07-27 | $0.00 derived: sum of 3 quarters · filed 2012-07-27 | $43.00K derived: sum of 4 quarters · filed 2012-11-06 | $7.31M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $0.00 derived: 10-Q 105 month − 10-K 102 month · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2012-05-08 | $43.00K derived: sum of 3 quarters · filed 2012-11-06 | $149.00K derived: sum of 4 quarters · filed 2012-11-06 | $7.31M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $43.00K derived: sum of 2 quarters · filed 2012-11-06 | $149.00K derived: sum of 3 quarters · filed 2012-11-06 | $316.00K 10-K · filed 2012-03-30 | $7.31M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $43.00K 10-Q · filed 2012-11-06 | $149.00K derived: sum of 2 quarters · filed 2012-11-06 | $316.00K 10-Q · filed 2012-11-06 | $542.00K derived: sum of 4 quarters · filed 2012-11-06 | $7.31M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | $106.00K 10-Q · filed 2012-07-27 | $273.00K 10-Q · filed 2012-07-27 | $499.00K derived: sum of 3 quarters · filed 2012-07-27 | $783.00K derived: sum of 4 quarters · filed 2012-07-27 | $7.27M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $167.00K 10-Q · filed 2012-05-08 | $393.00K derived: sum of 2 quarters · filed 2012-05-08 | $677.00K derived: sum of 3 quarters · filed 2012-05-08 | $1.02M derived: sum of 4 quarters · filed 2012-05-08 | ||||||
| 2010-12-31 | $226.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $510.00K derived: sum of 2 quarters · filed 2012-03-30 | $849.00K derived: sum of 3 quarters · filed 2012-03-30 | $1.24M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | $284.00K 10-Q/A · filed 2012-03-30 | $623.00K derived: sum of 2 quarters · filed 2012-03-30 | $1.02M 10-Q/A · filed 2012-03-30 | |||||||
| 2010-06-30 | $339.00K 10-Q/A · filed 2012-03-30 | $732.00K 10-Q/A · filed 2012-03-30 | ||||||||
| 2009-12-31 | $2.12M 10-K · filed 2012-03-30 |